Meeting
2022 ASCO Genitourinary Cancers Symposium
Comprehensive genomic profiling (CGP) of chromophobe renal cell carcinoma (chrRCC) compared with clear cell RCC (ccRCC): Impact of FLCN genomic alteration (GA) status.
Presenter
Gennady Bratslavsky, MD
SUNY Upstate Medical University
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
Rapid Oral Abstract Session
Session Title
Rapid Abstract Session C: Renal Cell Cancer and Rare Tumors
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 292)
DOI
10.1200/JCO.2022.40.6_suppl.292
Abstract #
292
Abstract Disclosures
Similar Videos & Slides
Videos & Slides
2022 ASCO Genitourinary Cancers Symposium
Comprehensive genomic profiling (CGP) of chromophobe renal cell carcinoma (chrRCC) compared with clear cell RCC (ccRCC): Impact of FLCN genomic alteration (GA) status.
Speaker: Gennady Bratslavsky, MD
Speaker: Panel Discussion
Speaker: Marios Konstantinos Tasoulis, MD, PhD, FRCS
Videos & Slides
2024 ASCO Annual Meeting
Racial differences in genomic profiles and targeted treatment use in ER+ HER2- metastatic breast cancer.
Speaker: Emily L Podany, MD